Clinical Trial Update: Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the safety of ramelteon in subjects with chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED